Detecting a signal in the noise : Monitoring the global spread of novel psychoactive substances using media and other open source information

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. Date of Acceptance: 16/02/2015To determine the feasibility and utility of using media reports and other open-source information collected by the Global Public Health Intelligence Network (GPHIN), an event-based surveillance system operated by the Public Health Agency of Canada, to rapidly detect clusters of adverse drug events associated with ‘novel psychoactive substances’ (NPS) at the international levelPeer reviewedFinal Published versio

‘Initiation into drug use’ addendum: findings from the DUMA program

The age at which an individual first experiments with illicit drugs has been of significant interest to policymakers and practitioners, primarily because research has persistently shown a link between early juvenile onset of drug use and less favourable health and criminal justice outcomes in adulthood.   drug users who have regular contact with the criminal justice system typically commenced their drug use at earlier ages (Gaffney et al. 2010; Johnson 2001);  even within the drug-using offender population, those with a recent history of violent or prolific property offending typically commenced drug use and progressed to regular drug use earlier than those with no such history (Makkai & Payne 2003); and  the risk that an offender will progress to serious and frequent offending was highest when both drug use and offending first began at younger than average ages (Payne 2006).    Although there is broad agreement that early initiation into drug use and subsequent involvement in the criminal justice system are correlated, there still remains considerable debate regarding the direction of causality. Some suggest that early drug use can act as a gateway or ‘stepping stone’ to more significant drug use and other problem behaviours (Kandel, Yamaguchi & Chen 1992), while others argue that drug use does not cause criminal behaviour, but rather, there is a shared or common aetiology, such as low self control or high impulsivity (Gottfredson & Hirschi 1990)

Market Analysis of Plant-based Drugs C. The Cannabis Market

An estimated quarter of a billion people, or around 5 per cent of the global adult population, used drugs at least once in 2015. Even more worrisome is the fact that about 29.5 million of those drug users, or 0.6 per cent of the global adult population, suffer from drug use disorders. This means that their drug use is harmful to the point that they may experience drug dependence and require treatment.The magnitude of the harm caused by drug use is underlined by the estimated 28 million years of "healthy" life (disability-adjusted life years (DALYs)) lost worldwide in 2015 as a result of premature death and disability caused by drug use.Of those years lost, 17 million were attributable solely to drug use disorders across all drug types. DALYs attributable to morbidity and mortality resulting from all causes of drug use have increased overall in the past decade.Yet, with fewer than one in six persons with drug use disorders provided with treatment each year, the availability of and access to science-based services for the treatment of drug use disorders and related conditions remain limited

Drug Use and Capital Accumulation

This paper admits that people are drug users and analyzes whether drug use affects the modified golden rule in the Ramsey model approach. The results show that in a steady state, this model's capital productivity is smaller than in the Ramsey model. However, the optimal intertemporal allocation of resources is ambiguous when the elasticity between drug use and the willingness to work is not null.

Drug use in the year after prison

With poor health and widespread drug problems in the U.S. prison population, post-prison drug use provides an important measure of both public health and social integration following incarceration. We study the correlates of drug use with data from the Boston Reentry Study (BRS), a survey of men and women interviewed four times over the year after prison release. The BRS data allow an analysis of legal and illegal drug use, and the correlation between them. We find that illegal drug use is associated with histories of drug problems and childhood trauma. Use of medications is associated with poor physical health and a history of mental illness. Legal and illegal drug use are not strongly correlated. Results suggest that in a Medicaid expansion state where health coverage is widely provided to people leaving prison, formerly-incarcerated men and women use medications, not illegal drugs, to address their health needs.Accepted manuscrip

The Drug Problem and Organized Crime, Illicit Financial Flows, Corruption and Terrorism

An estimated quarter of a billion people, or around 5 per cent of the global adult population, used drugs at least once in 2015. Even more worrisome is the fact that about 29.5 million of those drug users, or 0.6 per cent of the global adult population, suffer from drug use disorders. This means that their drug use is harmful to the point that they may experience drug dependence and require treatment.The magnitude of the harm caused by drug use is underlined by the estimated 28 million years of "healthy" life (disability-adjusted life years (DALYs)) lost worldwide in 2015 as a result of premature death and disability caused by drug use.Of those years lost, 17 million were attributable solely to drug use disorders across all drug types. DALYs attributable to morbidity and mortality resulting from all causes of drug use have increased overall in the past decade.Yet, with fewer than one in six persons with drug use disorders provided with treatment each year, the availability of and access to science-based services for the treatment of drug use disorders and related conditions remain limited

Beyond ‘peer pressure’: rethinking drug use and ‘youth culture’

The study of drug use by young people in the West has been transformed over the last decade by the development of sociological approaches to drug use which take serious account of the cultural context in which young people encounter drugs. One consequence is that the notion of ‘peer pressure’, as the primary articulation of the engagement between youth culture and drug use, has been displaced by that of ‘normalisation’, which envisages ‘recreational’ drug use as one expression of consumer-based youth cultural lifestyles. In stark contrast, academic discussion of drug use in Russia remains primarily concerned with the prevalence and health consequences of (intravenous) drug use while explanations of rising rates of drug use focus on structural factors related to the expansion of drugs supply and, to a lesser extent, post-Soviet social and economic dislocation. In this article, original empirical research in Russia is used to develop an understanding of young people's drug use that synthesises structural and cultural explanations of it. It does this by situating young people's narratives of their drugs choices in the context of local drugs markets and broader socio-economic processes. However, it attempts to go beyond seeing structural location as simply a ‘constraint’ on individual choice by adopting an understanding of ‘youth culture’ as a range of youth cultural practices and formations that simultaneously embody, reproduce and negotiate the structural locations of their subjects

Market Analysis of Synthetic Drugs: Amphetamine-type Stimulants, New Psychoactive Substances

An estimated quarter of a billion people, or around 5 per cent of the global adult population, used drugs at least once in 2015. Even more worrisome is the fact that about 29.5 million of those drug users, or 0.6 per cent of the global adult population, suffer from drug use disorders. This means that their drug use is harmful to the point that they may experience drug dependence and require treatment.The magnitude of the harm caused by drug use is underlined by the estimated 28 million years of "healthy" life (disability-adjusted life years (DALYs)) lost worldwide in 2015 as a result of premature death and disability caused by drug use.Of those years lost, 17 million were attributable solely to drug use disorders across all drug types. DALYs attributable to morbidity and mortality resulting from all causes of drug use have increased overall in the past decade.Yet, with fewer than one in six persons with drug use disorders provided with treatment each year, the availability of and access to science-based services for the treatment of drug use disorders and related conditions remain limited